Startups
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines. Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon. With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.
Overview
Location
Germany, Berlin
Employees
201-500
Founded date
1994
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 12, 2025 | Enabling Efficient Biomanufacturing Through Process Intensification, Upcoming Webinar Hosted by Xtalks | www.probiogen.de In this free webinar, learn what process intensification (PI) means for improving workflow speed and process yield. Attendees will gain insight into when and how to apply Intensified Fed-Batch (iFB), perfusion and High-Dens... |
| Mar 13, 2025 | Enhancing Antibody Therapeutics Through Precision Glycoengineering, Upcoming Webinar Hosted by Xtalks | www.probiogen.de In this free webinar, learn about advancements in cell line development and glycoengineering. Attendees will gain insights into how precise glycan modulation boosts antibody-dependent cell-mediated cytotoxicity (ADCC) activ... |
| Nov 5, 2024 | Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development | Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and ProBioGen, a leading CDMO in bi... |
| May 27, 2021 | ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company | BERLIN and CAIRO, May 27, 2021 /PRNewswire/ -- ProBioGen and Minapharm Pharmaceuticals announce the incorporation of ProBioGen's subsidiary "MiGenTra" with headquarters in Berlin and access to a site in Cairo, which will house its... |
Reviews 0
FAQ about ProBioGen AG
When was ProBioGen AG founded?
ProBioGen AG was founded in 1994.
What has the press written about ProBioGen AG?
Parsers VC has collected 5 articles mentioning ProBioGen AG, among them “Enabling Efficient Biomanufacturing Through Process Intensification, Upcoming Webinar Hosted by Xtalks” (May 12, 2025) and “Enhancing Antibody Therapeutics Through Precision Glycoengineering, Upcoming Webinar Hosted by Xtalks” (Mar 13, 2025).
Is ProBioGen AG still active?
Yes, ProBioGen AG is active; its latest activity on Parsers VC dates from Oct 20, 2025.